Advertisement
U.S. markets closed
Advertisement

Alkermes plc (ALKS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
24.29+0.15 (+0.62%)
At close: 04:00PM EST
25.93 +1.64 (+6.75%)
After hours: 07:58PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Performance Outlook
Previous Close24.14
Open24.19
Bid25.51 x 800
Ask24.97 x 900
Day's Range24.00 - 24.42
52 Week Range22.01 - 33.71
Volume4,313,230
Avg. Volume1,865,722
Market Cap4.054B
Beta (5Y Monthly)0.62
PE Ratio (TTM)19.59
EPS (TTM)1.24
Earnings DateFeb 16, 2024 - Mar 02, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est33.09
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ALKS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Alkermes plc
    EXEL: What does Argus have to say about EXEL?EXELIXIS INC has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • PR Newswire

    Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-

  • ACCESSWIRE

    Pharmaceuticals in the Environment

    NORTHAMPTON, MA / ACCESSWIRE / November 29, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportWe understand the significant potential impacts that pharmaceuticals can have on the environment. We maintain ...

  • Investor's Business Daily

    The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

    The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.